We decided to utilize more of our capital for long run investments, this time in the biotechnology sector with the iShares IBB ETF. We did the following:
- Buy 4 shares of IBB at $258.78.
Our long term thesis is that biotechnology is a sector that will see tremendous advances. Biotech has pulled back and we see this as a buying opportunity.
– Michael and Nolan